Samuel Brusco, Associate Editor09.16.22
Terumo Cardiovascular celebrated the opening of its newest manufacturing plant in La Lima, Cartago, Costa Rica.
The new facility houses the company’s Perfusion Circuit Technology and Manufacturing Center. Terumo is the first company to make this kind of medical equipment in Costa Rica. Terumo invested $42 million in global manufacturing operations.
The facility is 157,000 square feet with state-of-the-art systems and a highly-trained workforce. Operations launched on August 3 and will mainly serve customers in the Americas and Australia. A second phase will launch in early 2023 to supply Europe, the Middle East, and Africa (EMEA).
"May this opening ceremony give rise to greater projects, where the quality of Costa Rican talent finds a place in best-in-class multinational operations such as Terumo, which has reached more than 160 countries and regions. Friends let's make this century of common history be one of great achievements together, where through commitment, excellence, vision, and technology we will reach together a new era of growth, both for Terumo and for the country," Rodrigo Chaves, the President of Costa Rica, told the press.
"Our focus is on the patient. By strengthening our perfusion circuit manufacturing footprint in Costa Rica, Terumo Cardiovascular is better positioned to serve our global customers and provide effective solutions for patient care—today and well into the future," commented Terumo Cardiovascular Robert DeRyke. "Costa Rica has a strong cultural alignment with Terumo Cardiovascular and the countries where we operate. Its economic and political stability, and strong commitment to sustainability, is an ecosystem-strengthening draw for numerous service and medical device manufacturers that tap into their highly skilled talent. This opening enhances our global competitiveness and helps us grow based on strategic investments."
The new facility houses the company’s Perfusion Circuit Technology and Manufacturing Center. Terumo is the first company to make this kind of medical equipment in Costa Rica. Terumo invested $42 million in global manufacturing operations.
The facility is 157,000 square feet with state-of-the-art systems and a highly-trained workforce. Operations launched on August 3 and will mainly serve customers in the Americas and Australia. A second phase will launch in early 2023 to supply Europe, the Middle East, and Africa (EMEA).
"May this opening ceremony give rise to greater projects, where the quality of Costa Rican talent finds a place in best-in-class multinational operations such as Terumo, which has reached more than 160 countries and regions. Friends let's make this century of common history be one of great achievements together, where through commitment, excellence, vision, and technology we will reach together a new era of growth, both for Terumo and for the country," Rodrigo Chaves, the President of Costa Rica, told the press.
"Our focus is on the patient. By strengthening our perfusion circuit manufacturing footprint in Costa Rica, Terumo Cardiovascular is better positioned to serve our global customers and provide effective solutions for patient care—today and well into the future," commented Terumo Cardiovascular Robert DeRyke. "Costa Rica has a strong cultural alignment with Terumo Cardiovascular and the countries where we operate. Its economic and political stability, and strong commitment to sustainability, is an ecosystem-strengthening draw for numerous service and medical device manufacturers that tap into their highly skilled talent. This opening enhances our global competitiveness and helps us grow based on strategic investments."